Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Open Label Investigation of the Efficacy and Durability of Once Daily Antiretroviral Therapy With Kaletra and Viread in Antiretroviral Naïve Patients.

NCT00679926 is registered in ClinicalTrials.gov with Oklahoma State University Center for Health Sciences as lead sponsor.

NCT NCT00679926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00679926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Open Label Investigation of the Efficacy and Durability of Once Daily Antiretroviral Therapy With Kaletra and Viread in Antiretroviral Naïve Patients.
Lead sponsor
Oklahoma State University Center for Health Sciences
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2008
Completion date
May 31, 2011
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections